Silence Therapeutics (SLN) Intangibles (2019 - 2025)
Silence Therapeutics (SLN) has disclosed Intangibles for 7 consecutive years, with $288000.0 as the latest value for Q4 2025.
- Quarterly Intangibles fell 7.69% to $288000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $288000.0 through Dec 2025, down 7.69% year-over-year, with the annual reading at $288000.0 for FY2025, 7.69% down from the prior year.
- Intangibles hit $288000.0 in Q4 2025 for Silence Therapeutics, down from $300000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $375337.1 in Q4 2022 to a low of $175241.4 in Q4 2021.
- Historically, Intangibles has averaged $303758.2 across 5 years, with a median of $311000.0 in 2024.
- Biggest five-year swings in Intangibles: skyrocketed 114.18% in 2022 and later fell 11.49% in 2024.
- Year by year, Intangibles stood at $175241.4 in 2021, then surged by 114.18% to $375337.1 in 2022, then fell by 6.09% to $352487.1 in 2023, then dropped by 11.49% to $312000.0 in 2024, then fell by 7.69% to $288000.0 in 2025.
- Business Quant data shows Intangibles for SLN at $288000.0 in Q4 2025, $300000.0 in Q3 2025, and $317000.0 in Q2 2025.